Multimodal Training With Immersive Virtual Reality to Improve the Cognitive Health and Emotional Well-being of Older Women Living Alone
NCT ID: NCT06956794
Last Updated: 2025-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
80 participants
INTERVENTIONAL
2025-05-05
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immersive Virtual Reality Training for Improving Cognition in Adults With Metabolic Syndrome
NCT07040748
Inclusive Rehabilitation: Virtual Reality as a Tool to Improve the Quality of Life of Dependent Persons
NCT06928155
Virtual Reality for Mental Well-being in Older People With Physical Disabilities
NCT05818579
Contribution of Virtual Reality to the Well-being of Elderly Patients Hospitalized in SMR
NCT06985732
Virtual Reality for Vocational Recovery
NCT07114887
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
These social and economic determinants significantly increase the likelihood of developing dementia and/or mental health disorders in affected individuals. Research has established a connection between social isolation, aging, and a higher probability of experiencing dementia, stress, depression, and anxiety. Economic uncertainty is also known to contribute to stress and anxiety, while social stigma-particularly affecting older women-can negatively impact their cognitive and mental health.
All of these factors highlight the need for preventive interventions targeting women over the age of 65 who live alone and have incomes below the minimum income threshold. VirtualDONA proposes a preventive intervention for this population using immersive virtual reality technology (without headsets) to improve cognitive functioning, emotional well-being, and quality of life.
The intervention will be delivered in a group format over 8 weeks (16 sessions). The combination of mindfulness, cognitive, and physical exercises within a virtual environment offers a suitable multimodal platform for a comprehensive and innovative intervention aimed at vulnerable women. The project aims to demonstrate the benefits of this approach and to develop a sustainable, scalable, and long-term viable business model.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immersive VR-Based Multimodal Intervention
Participants in this arm will receive a multimodal, group-based intervention using immersive virtual reality without headsets. The intervention includes mindfulness, cognitive training, and physical exercises delivered in 16 group sessions over 8 weeks.
VirtualDONA Multimodal Program
A group-based behavioral intervention using immersive virtual reality without headsets. The 8-week program includes 16 sessions combining mindfulness, cognitive training, and physical exercises, designed to improve cognitive health and emotional well-being in older women living alone and at risk of poverty.
Usual Activity (Control Group)
Participants in this arm will continue their usual daily routines with no specific intervention during the study period.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VirtualDONA Multimodal Program
A group-based behavioral intervention using immersive virtual reality without headsets. The 8-week program includes 16 sessions combining mindfulness, cognitive training, and physical exercises, designed to improve cognitive health and emotional well-being in older women living alone and at risk of poverty.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 65 years or older
* Living alone
* Registered with the elderly care services of Suara Cooperativa
* Annual income below the guaranteed minimum income threshold (below €20,353.62/year)
* Global cognitive functioning not suggestive of dementia, defined as MMSE score ≥ 24
* Able to read and write
* Good command of Catalan and/or Spanish
* Signed informed consent to participate in the study
Exclusion Criteria
* Uncorrected sensory deficits (e.g., vision or hearing)
* Physical or motor impairments that may interfere with participation or bias outcome measures
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Broomx Technologies
UNKNOWN
SUARA Cooperativa
UNKNOWN
Consorci Sanitari de Terrassa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maite Garolera
Chief of the Neuropsychological Unit and Director of the Brain, Cognition, and Behavior Research Group
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maite Garolera, PhD
Role: PRINCIPAL_INVESTIGATOR
Consorci Sanitari de Terrassa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SUARA Cooperativa
Barcelona, Barcelona, Spain
Consorci Sanitari de Terrassa
Terrassa, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024PROD00053
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.